A new lab model tests a drug that may slow brain tumor spread
Original title: Brain assembloids reveal efficacy and off target effects in high grade glioma brain cancer.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was done only in lab-grown cells and tissue, not in people.
The short version
Scientists built a lab model to check if a drug stops tumor cells from spreading, and whether it also harms healthy brain cells.
What was studied. Researchers grew clumps of high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary cells, a type of brain cancer. They also joined some clumps to brain-like tissue grown from stem cells. Then they tested a drug called PTU, made from an omega 3 fatty acid.
What they found. PTU made tumor cells round up and blocked them from invading in a gel test. In the brain-like tissue, the effect was not the same for every tumor cell line. Tests also showed PTU changed signals in the healthy brain tissue, not just in the cancer cells.
What this means, and what it doesn't
What it could mean: This gives scientists a better way to check both the good and the bad effects of these drugs before people are involved. The work is about the testing method as much as the drug.
What it doesn't mean: This is not a treatment you can ask for. The work was done only in cells and lab-grown tissue, not in people or animals. It does not show that PTU helps anyone live longer or feel better. It is not a cure.
Source: PubMed, August 19, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.